Background. Human ficolin-2 (L-ficolins) encoded by the FCN2 gene are pattern-recognition proteins involved in innate immunity and are associated with several infectious diseases.
Schistosomiasis is a major human parasitic disease that is caused by different species of trematode of the genus Schistosoma in sub-Saharan Africa. The most prevalent species in sub-Saharan Africa is S. haematobium and accounts for urogenital schistosomiasis and severe pathological conditions such as hematuria, hydronephrosis, and bladder cancer [1] [2] [3] . Of the world's 207 million estimated cases of schistosomiasis, 93% occur in sub-Saharan Africa (192 million), with Nigeria recording the largest number of registered cases (29 million) followed by the United Republic of Tanzania (19 million) and the Democratic Republic of Congo and Ghana (15 million each) [4] . S. haematobium is highly endemic in all Nigerian states, and the most affected age group is school-aged children [5] .
Schistosomes are complex multicellular organisms that occur in different developmental stages in the host. The pathogen S. haematobium carries glycoconjugates at all developmental stages with a novel combination of glycans that can interact with the innate immune system's recognition elements. The fundamental attribute of the innate immune system is its ability to recognize a pathogen and react swiftly to contain the early infection while signaling a specific adaptive immune response [6] . Ficolins are a vital innate immune recognition protein that is involved in immune defense against pathogens [7] . Three ficolins have been identified in humans: M-ficolin (ficolin-1), L-ficolin (ficolin-2), and H-ficolin (ficolin-3). Ficolin-2, which is encoded by the FCN2 gene, is located on chromosome 9 and has 8 exons [8] . Ficolin-2 exists in the circulation system as an oligomer, and each monomer is a 35-kDa protein with an N-terminal, middle collagen-like domain, and C-terminal fibrinogen-like domain. The 4 ligand-binding sites (S1 to S4) in the fibrinogen-like domain are responsible for recognizing carbohydrate sugars such as N-acetylglucosamine (GIcNAc) and other acetylated compounds on the pathogen's surface [8, 9] . Also ficolin-2 is known to bind specifically to lipoteichoic acid on the cell wall of bacteria and to 1, 3-β-D-glucan of fungal and yeast cell walls [10, 11] . Similar to mannose-binding lectin (MBL), ficolins bind to specific pathogen-associated molecular patterns (PAMPs) on the pathogen surface that are in association with the MBL-associated serine proteases (MASP1 and MASP2). Ficolin-2 initiates the complement lectin cascade, thereby clearing the pathogens by opsonization [12] . Human ficolin-2 is mainly expressed in the liver and is observed in serum at an average concentration of 4.15 µg/mL [13] . Three polymorphisms in the promoter region of the FCN2 gene (−986G>A, −602G>A, and −4A>G) are markedly associated with lower ficolin-2 serum levels. The FCN2 variant in exon 8 (+6424 G>T) with amino acid substitution (Ala258Ser) has been demonstrated to have elevated binding capacity to GIcNAC compared with the major allele [9, 14] .
Prevalence of schistosomiasis within endemic communities may be influenced by several exposure-related factors such as local environment and behavior as well as genetic factors relating to individual susceptibility [15] . Studies on schistosomiasis have documented that recurrent infections are due to individual variability in certain families and are not randomly distributed [16] . Several genetic association studies of schistosomiasis have focused on the Th2 gene cluster, especially IL4, IL5, and IL13 gene polymorphisms in the 5q31-q33 region [17] . Knowledge of the role of MBL2 and FCN2 gene polymorphisms is essential to understanding the role of innate immune recognition elements in pathogen clearance, yet schistosomiasis infection has rarely been studies. In earlier studies, the possible associations between FCN2 gene polymorphisms and ficolin-2 levels in patients with rheumatic fever, rheumatic heart disease, leprosy, respiratory tract infection, and malaria have been investigated [18] [19] [20] [21] [22] .
In schistosomiasis, the adult worm resides in the venous plexus of the urinary tract for approximately 5-10 years [23] . The adult worm and the cercaria contain carbohydrate sugars such as N-acetylglucosamine, N-acetylgalactosamine, glucose, and fucose, which remain potential targets for ficolins [24] . In this study, we investigated the role of ficolin-2 during S. haematobium infection. We examined the possible contribution of the functional FCN2 variants (3 in the promoter and 1 in exon 8) and investigated the role of genetic polymorphisms in the circulation of serum ficolin-2 levels in a Nigerian cohort.
PATIENTS AND METHODS

Study Design
Two villages with known histories of S. haematobium in southwest Nigeria were chosen for the study: Ilewo Orile (Abeokuta North) of Ogun state and Ore (Osogbo) of Osun state. Both communities lack a clean water supply, safe waste disposal, and essential health centers. Community members depend on nearby rivers for their daily needs (eg, drinking water, washing clothes, and bathing), and fishermen and traders are the most represented population. Epidemiological studies of urinary schistosomiasis in Ogun state, Nigeria, revealed an infection rate of greater than 80% [25] . This is a cross-sectional study, and individuals were recruited blindly irrespective of their infection status. Informed consent (in the local language) was obtained from all participants; for children, consent was obtained from the parents and/or guardians. Only those who provided consent were recruited into the study. Ethical approval was obtained from the Ethical Committee of Ministry of Health, Abeokuta Ogun State, Nigeria.
Urine samples were collected from all individuals. Based on the result of the microscopic examination of urine, individuals were divided into 2 groups: those positive for S. haematobium egg in urine (SEP) and those negative for S. haematobium egg in urine (the control group). The control group was further screened to estimate the levels of antischistosomal total immunoglobulin G (IgG) antibodies. Based on these levels, the control group was divided into 2 subgroups: those positive for antischistosomal total IgG antibodies and negative for egg in urine (SELP) and those negative for antischistosomal total IgG antibodies and negative for egg in urine (SELN). This classification of the control group is essential in schistosomaendemic areas because it is difficult to differentiate between individuals without a current infection who are either less susceptible or have not been exposed to infection. Therefore, detection of antischistosomal total IgG was used as a diagnostic exposure marker.
Sample Collection
About 10 mL of urine was collected in a sterile, labeled container from all participants. The samples were centrifuged at 5000 rpm for 5 minutes. The supernatant was discarded and the remaining sediment was transferred to a clean glass slide that was examined microscopically for the presence of S. haematobium eggs. For negative individuals, urine samples were collected on 3 successive days. A reagent strip, Combur-Test (Roche Diagnostics GmbH, Mannheim, Germany), was used to estimate the degree of hematuria and proteinuria according to the manufacturer's directions. About 5 mL of blood was collected from all study participants for serological assays and subsequent DNA extraction. Those positive for urinary schistosomiasis were treated with a single 40-mg/kg dose of praziquantel. Stool samples were collected from all participants and processed using the Kato-Katz method in order to exclude any Schistosoma mansoni infection.
After parasitological and serological testing, the cohort was divided into the following 3 groups: cases, first control group, and second control group. The cases group was the SEP group: n = 168; 93 (55%) children, 44 (26%) males, 31 (19%) females; mean age 18.4 ± 12.4. The first control group was the SELP group: n = 123; 22 (18%) children, 51 (42%) males, 50 (40%) females; mean age 33.4 ± 18.8. The second control group was the SELN group: n = 69; 33 (48%) children, 19 (28%) males, 17 (24%) females; mean age 20.1 ± 17.2. All study subjects were of Yoruba ethnicity representing the Nigerian population. 
Serological Assays
Using a modified protocol [26] , serological assays using enzyme-linked immunosorbent assay (ELISA) were performed to detect antischistosomal total IgG antibodies in sera using adult worm antigen. Briefly, ELISA wells were coated overnight with schistosoma adult antigen. Plasma samples and positive and negative controls were diluted 1:100 with milk buffer; 200 µL of the test samples and controls was dispensed into the wells and incubated for 1 hour at room temperature. The contents of the wells were discarded and then washed 5 times with wash buffer. Then 200 µL of conjugate was added to each well and incubated for 1 hour at room temperature. The contents of the wells were discarded and washed 5 times with washing buffer. Next, 200 µL of substrate was added to each well and incubated for 15 minutes; the optical density was measured at 405 nm. The ficolin-2 level in serum was estimated by ELISA using a commercially available kit (Life Science Incorporated, China) according to the manufacturer's instruction.
FCN2 Genotyping
Genomic DNA was extracted using a QIAamp DNA mini blood kit (Qiagen, Hilden, Germany) according to the manufacturer's instruction. Genotyping of 3 single-nucleotide polymorphisms (SNPs) in the promoter of the FCN2 gene (−986G>A −602G>A and −4A>G) and 1 in exon 8 (+6424G>T) was performed using fluorescence resonance energy transfer real-time polymerase chain reaction (RT-PCR). FCN2 genotyping was performed using the primers and probes as described in the literature [27] . Briefly, an asymmetrical PCR was performed as a 2-step procedure in the Rotor Gene 3000 (Corbett, Sydney, Australia). The PCR was performed in a 20-µL reaction volume containing 50 ng of genomic DNA, 1× concentration of QuantiTect Multiplex PCR NoRox Master Mix (Qiagen, Hilden, Germany), 0.2 µM of the hybridization probes, 0.05 µM of the primer (either forward or reverse), and 0.5 µM of the primer (either reverse or forward). The thermal cycling parameters for the first step are as follows: an initial denaturation at 95°C for 15 minutes, followed by 40 cycles of denaturation at 94°C for 1 minute, followed by annealing and extension at 60°C for 1 minute. For the second step, the parameters are as follows: denaturation at 95°C for 1 minute, cooling to 40°C for 1 minute, increasing the temperature to 90°C by increasing each 1 degree and holding for 2 seconds, with a final cooldown to 40°C for 60 seconds. Negative and positive controls were included for all PCRs. All genotypes were validated by the melting temperature of their probes using the Rotor-Gene software (version 6.1.81; Corbett, Sydney, Australia).
Statistical Analysis
Data were analyzed using StatView (http://www.statview.com); the level of significance was set at P <.05. The Kruskal-Wallis test was used to analyze the correlation of serum ficolin-2 levels to FCN2 gene variants. The 2-tailed Fisher's exact test was performed to determine the differences in allele frequencies and genotype distributions. Genotype or haplotype frequencies were analyzed by simple gene counting and expectation-maximum algorithm, and the significance of deviations from Hardy-Weinberg equilibrium was tested using the random-permutation procedure as implemented in the Arlequin software (version 3.5.1.2; http://lgb.unige.ch/arlequin). Linkage disequilibrium (LD) analysis was performed using the Haploview program (version 3.2).
RESULTS
FCN2 Gene Polymorphisms and S. haematobium Infection Risk
Both genotype and allele frequencies for the 3 analyzed SNP variants (−986G>A, −4A>G, +6424G>T) in each group were in Hardy-Weinberg equilibrium except for the −602G>A variant. Significant differences were observed either in genotypes or in allelic distributions between the patients (SEP) and the control groups (SELP, SELN, SELP + SELN; Tables 1-3 ). The −986G>A and −4A>G genotypes were distributed significantly between the infected group and either of the 2 control groups. The heterozygous genotype GA (−986G>A) was found more frequently in infected individuals than in either of the control groups. Abbreviations: CI, confidence interval; OR, odds ratio; SELP, negative for Schistosoma haematobium egg in urine but positive for antischistosomal total IgG; SEP, diagnosed with S. haematobium egg in urine. Two main haplotypes, AGGG and GGAG (−986/−602/−4/ +6424), were found at higher frequencies. The other haplotypes, GGAT, AGAG, GGGG, AAAT, and GGGT (−986/ −602/−4/+6424), were also observed, but at lower frequencies, and remained insignificant when compared with cases and control groups (data not shown). The FCN2 haplotype AGGG (−986/−602/−4/+6424) was found more frequently in SEP cases when compared with both control groups, including combined controls. For SEP cases vs SELP controls: OR, 2.3; 95% CI, 1.4-3.7; P = .0002; for SEP cases vs SELN controls: OR, 1.7; 95% CI, 1.0-3.0; P = .03; and for SEP cases vs SELP + SELN controls: OR, 2.0; 95% CI, 1.4-3.1; P = .0002). The FCN2 haplotype GGAG (−986/−602/−4/+6424) was observed more frequently in SELP controls compared with SEP cases: OR, 0.7; 95% CI, .4-1.0; P = .04 (Table 4) . LD analysis revealed strong allelic combinations at positions −986G>A and −4A>G in both cases and controls (Figure 1 ). Moreover, a stronger LD was (5) 12 (6) Abbreviations: CI, confidence interval; OR, odds ratio; SELN, negative for Schistosoma haematobium and antischistosomal total IgG; SELP, negative for S. haematobium egg in urine but positive for antischistosomal total IgG; SEP, diagnosed with S. haematobium egg in urine.
observed between positions −986G>A and −4A>G in schistosomiasis-infected individuals with an LD >47.
Ficolin-2 Serum Levels and S. haematobium Infection Risk
Ficolin-2 serum levels varied significantly between cases (SEP, mean 8.2 µg/mL ± 5.2) and control groups (SELP, mean 12.2 µg/mL ± 5.6; P < .0001). No significant differences were observed when SEP cases were compared with SELN controls (mean 6.7 µg/mL ± 4.4; Figure 2A ). A significant difference was found between cases (SEP, mean 8.2 µg/mL ± 5.2) and the combined controls (SELP + SELN, mean 10 µg/mL ± 5.8], P = .005; Figure 2B ). Increased ficolin-2 serum levels were observed in individuals who were positive for total antischistosomal IgG (SELP).
Association Between FCN2 Haplotypes and Serum Ficolin-2 Levels
The SELP ( positive for total antischistosomal IgG) controls with the AGGG haplotype had increased ficolin-2 serum levels compared with SEP patients (P < .0005; Figure 3A) . The SEP patients (egg-positive individuals) with the GGAG haplotype had lower ficolin-2 serum levels compared with both SELP and SELP + SELN control groups (P < .0001; Figure 3B ).
DISCUSSION
To the best of our knowledge, this is the first study to address the role of FCN2 gene polymorphisms in schistosomiasisinfected individuals. The host immune system uses different immune strategies to thwart an infection efficiently, and an innate immune system plays a critical role in the clearance of pathogens. The role of different immunological processes in the resolution of infection is not well understood. Ficolin-2 molecules are pattern-recognition molecules that are involved in the innate immune response and thus serve as the first line of defense against any pathogens that are present. Ficolins are able to bind to specific ligands such as PAMPs, which are expressed on the pathogens' surface, and trigger the complement cascade by interacting with MASPs [8] . In previous studies we demonstrated that MBL binds to the sugar moieties of S. mansoni cercariae and adult worms in vitro. We also demonstrated that MBL together with MASP1 and MASP2 are capable of interacting with the schistosoma tegument, thereby activating the complement cascade [28] . We therefore hypothesized in the current study that FCN2 gene polymorphisms and circulating serum ficolin levels play a vital role in the susceptibility of schistosomiasis. We investigated the possible association of FCN2 gene polymorphisms and circulating ficolin-2 serum levels with susceptibility of S. haematobium infection in a cohort of patients and 2 control groups. The subgrouping of the control group (SELP + SELN) provided clear resolution for controls, especially in endemic areas where it is difficult to identify individuals with an ongoing infection (either individuals who are less susceptible or have not been exposed to infection).
In our earlier studies we demonstrated that FCN2 gene polymorphisms at positions −986G>A, −602 G>A, −4A>G, and at +6424G>T influence the circulating ficolin-2 serum levels [14] . Lower ficolin-2 serum levels and genetic polymorphisms have been shown to be associated with susceptibility to several infectious diseases such as respiratory infections in children and invasive pneumococcal disease in adults [18, 19, 29] . In our earlier studies we also investigated the possible associations between FCN2 genotypes and haplotypes and ficolin-2 levels in rheumatic fever, rheumatic heart disease, leprosy, and malaria [20] [21] [22] . In the current study, the heterozygous genotypes GA and AG, which represent positions −986 G>A and −4 A>G, respectively, were observed to influence predisposition to schistosomiasis. Both minor alleles (−986A and −4G) were observed to significantly contribute to increased susceptibility, whereas the homogenous genotypes GG and AA were observed to confer protection against infection. The results remained consistent when egg-positive patients (SEP) were compared with the different control groups and even with the pooled control group (Tables 1-3 ). The −986A allele revealed increased risk to susceptibility and the −4G allele also contributed to increased risk of infection. These results imply that individuals who are homozygous for the major allele at promoter positions −986G>A and −4A>G are less likely to be infected and that individuals who are heterozygous at promoter positions −986G>A and −4A>G are more prone to infection. The LD results confer that both SNPs (−986G>A and −4A>G) were closely linked to each other in the infected individuals (LD > 47) when compared with controls ( Figure 1A) . In earlier studies we observed that relatively few individuals in schistosomiasis-endemic areas were more susceptible to infection than the rest of the population, suggesting that genetic factors, especially individual variability, might contribute to infection outcome [30] . Also of note, a study of a population of fishermen from Uganda showed that the intensity of infection in the Alur tribe was not related to frequency of exposure to parasites but rather that genetic factors may determine susceptibility to schistosomiasis [31] .
In this study, the haplotype −986/−602/−4/+6424 AGGG, which is associated with higher ficolin levels, was observed more frequently in patients than in SELP controls (OR, 2.3). Interestingly, when the SELN and SELP + SELN ( pooled) controls were analyzed, no significant differences were observed in the same haplotype. This result supports the belief that this particular haplotype plays a vital role in the progression of schistosomiasis to a chronic state. Also, a significant higher frequency of the haplotype −986/−602/−4/+6424 GGAG, which is associated with lower ficolin levels, was observed more Figure 3 . Distribution of ficolin-2 serum levels in haplotypes. A, Distribution of ficolin-2 serum levels in GGAG haplotype between patient group (SEP, diagnosed with Schistosoma haematobium egg in urine), control one (SELP, negative for S. haematobium egg in urine but positive for antischistosomal total IgG), control two (SELN, negative for S. haematobium egg and antischistosomal IgG), and the combined controls (SELP + SELN). B, Distribution of ficolin-2 serum levels in AGGG haplotype among patient group (SEP), control one (SELP), control two (SELN), and combined controls (SELP + SELN). Numbers in parentheses indicates absolute counts of GGAG haplotype in each group.
frequently in SELP controls than in patients (OR, 0.7). Also, when the SELP + SELN ( pooled) controls were analyzed, significant differences were observed with the same haplotype (P < .0001), supporting the idea that the haplotype confers a protective effect on exposure. In addition, these results indicate that this haplotype may play a role in preventing reinfection with S. haematobium because the haplotype was found more frequently in the SELP group, which is exposed to infection as remained positive for antischistosomal IgG antibodies that implies no current infection.
Ficolin-2 serum levels varied significantly between cases and the control group. A significant difference was found between cases and the combined controls ( Figure 2B ). Increased ficolin-2 serum levels were observed in individuals who were positive for total antischistosomal IgG (SELP group). The ficolin-2 serum level was significantly higher in the control group compared with infected individuals, showing that high levels of ficolin could have a protective role by reducing susceptibility to S. haematobium infection. Similar results were observed in children with recurrent respiratory infection where an association between relative ficolin-2 deficiency and recurrent respiratory infections coexists with allergic disorders [18] . In one of our recent studies we demonstrated the association of functional haplotypes with the development of clinical leprosy, unveiling a role for ficolin-2 in protecting against Mycobacterium leprae [20] .
Finally, our data suggest that both the FCN2 -986A allele and the −4G allele were significantly associated with the occurrence of schistosomiasis and that the heterozygous genotypes at positions −986G>A and −4A>G were a risk factor for susceptibility to schistosomiasis. The −986/−602/−4/+6424 AGGG haplotype represents a novel risk factor, with GGAG being protective against schistosomiasis. Overall, we believe that FCN2 gene polymorphisms may remain as an additional factor that contributes to susceptibility to schistosomiasis.
Notes
